A team of scientists from La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases
The scientific discovery, published in the prestigious journal Nature Communications could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.
Dr Mark Hulett and Dr Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.
“Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years,” Dr Hulett said.
“Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It’s imperative we develop new antibiotic treatments.”
Using the power of the Australian Synchrotron, the team led by Dr Hulett and Dr Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.
The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.
“They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.
“It’s an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multi-drug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis.”
In 2014, Dr Hulett and Dr Kvansakul found NaD1 could also be effective in killing cancer cells.
Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.
Nicotiana alata flowers naturally produce potent anti-fungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.
Learn more: La Trobe’s infection-busting discovery
The Latest on: Antimicrobial therapy
via Google News
The Latest on: Antimicrobial therapy
HIV Biologic Drug Reduces Viral Load While Boosting Immunity
on August 16, 2018 at 7:32 am
As antimicrobial resistance is a growing global public health threat, researchers are actively taking steps to minimize the emergence and spread of HIV drug resistance—as well as treating current HIV ... […]
Good News on Antibiotic Effectiveness to Drug-Resistant Bacteria
on August 15, 2018 at 5:30 am
In their Antimicrobial Agents and Chemotherapy study ... and infections with resistant pathogens could potentially be treated with the combination therapy. Of particular interest, colistin demonstrate... […]
Combination therapy may be useful against resistant bacteria
on August 13, 2018 at 7:40 am
in their Antimicrobial Agents and Chemotherapy study. The scientists discovered several potential combinations where synergy was detected, and as such infections with resistant pathogens could be trea... […]
FDA Panel Votes on Therapy for Nontuberculous Mycobacterial Lung Disease
on August 9, 2018 at 2:09 pm
Insmed announced that the Food and Drug Administration (FDA)'s Antimicrobial Drugs Advisory Committee voted ... significance in favor of once-daily ALIS with guideline-based therapy (GBT) vs GBT alone ... […]
Herbal drug to prevent antimicrobial resistance in cattle
on July 30, 2018 at 12:13 am
Since persistence of antibiotics for a prolonged period in milk triggers antimicrobial resistance (AMR), the polyherbal drug could be used as a supportive therapy to treat sensitive bacterial infectio... […]
Antimicrobial therapy can prevent sepsis in pneumonia patients
on April 16, 2018 at 8:04 am
Antimicrobial therapy targeting specific cells in the immune system could prevent sepsis and life-threatening disease in people suffering from pneumonia, new research led by the University of Leiceste... […]
Blog Exposure - FDA Granted New 510(k) Clearance to Sonoma Pharma’s Antimicrobial Post-Therapy Gel
on April 9, 2018 at 5:48 am
LONDON, UK / ACCESSWIRE / April 09, 2018 / Active-Investors.com has just released a free research report on Sonoma Pharma, Inc. (NASDAQ: SNOA). If you want access to this report all you need to do is ... […]
Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy Gel
on April 5, 2018 at 4:21 am
April 05, 2018 07:05 ET | Source: Sonoma Pharmaceuticals, Inc. PETALUMA, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceuti... […]
FDA clears Sonoma Pharma's antimicrobial post-therapy gel
on April 5, 2018 at 4:19 am
The FDA grants 510(k) clearance for Sonoma Pharmaceuticals' (NASDAQ:SNOA) antimicrobial post-therapy gel for the management of post-non-ablative laser therapy procedures, post-microdermabrasion therap... […]
via Bing News